BridgeBio Pharma (BBIO) Short Interest Ratio & Short Volume → What is the 72-Hour Profit Surge? (From DTI) (Ad) Free BBIO Stock Alerts $24.74 +0.41 (+1.69%) (As of 10:04 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability BridgeBio Pharma Short Interest DataCurrent Short Volume15,070,000 sharesPrevious Short Volume14,280,000 sharesChange Vs. Previous Month+5.53%Dollar Volume Sold Short$388.35 millionShort Interest Ratio / Days to Cover8.9Last Record DateApril 15, 2024Outstanding Shares175,830,000 sharesFloat Size138,830,000 sharesShort Percent of Float10.86%Today's Trading Volume44,887 sharesAverage Trading Volume1,741,167 sharesToday's Volume Vs. Average3% Short Selling BridgeBio Pharma ? Sign up to receive the latest short interest report for BridgeBio Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBBIO Short Interest Over TimeBBIO Days to Cover Over TimeBBIO Percentage of Float Shorted Over Time Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about BridgeBio Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202415,070,000 shares $388.35 million +5.5%10.9%8.9 $25.77 3/31/202414,280,000 shares $441.54 million +6.5%10.3%8.3 $30.92 3/15/202413,410,000 shares $369.58 million -1.7%9.8%7.3 $27.56 2/29/202413,640,000 shares $465.81 million -2.6%10.0%7.1 $34.15 2/15/202414,000,000 shares $549.22 million -1.5%10.8%7.9 $39.23 1/31/202414,210,000 shares $487.26 million -11.9%11.1%8.3 $34.29 Get the Latest News and Ratings for BBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BridgeBio Pharma and its competitors with MarketBeat's FREE daily newsletter. 1/15/202416,120,000 shares $623.84 million -5.6%12.6%9.7 $38.70 12/31/202317,080,000 shares $689.52 million -0.1%13.3%11 $40.37 12/15/202317,090,000 shares $672.83 million +7.1%13.3%11.4 $39.37 11/30/202315,960,000 shares $458.21 million -2.0%12.8%11.2 $28.71 11/15/202316,280,000 shares $480.59 million +1.9%13.0%10.8 $29.52 10/31/202315,970,000 shares $415.86 million -0.6%12.7%9.9 $26.04 10/15/202316,060,000 shares $418.84 million +4.8%13.7%9 $26.08 9/30/202315,320,000 shares $403.99 million -4.1%13.1%5.1 $26.37 9/15/202315,980,000 shares $465.50 million +4.2%13.6%5.2 $29.13 8/31/202315,330,000 shares $458.52 million -2.1%13.1%4.9 $29.91 8/15/202315,660,000 shares $477.00 million +8.5%13.4%5.1 $30.46 7/31/202314,430,000 shares $505.19 million -2.6%12.3%4.7 $35.01 7/15/202314,820,000 shares $270.02 million -0.6%12.8%5 $18.22 6/30/202314,910,000 shares $256.45 million +13.2%12.8%8.1 $17.20 6/15/202313,170,000 shares $204.40 million -2.5%11.3%6 $15.52 5/31/202313,510,000 shares $185.36 million +1.7%11.7%5.9 $13.72 5/15/202313,290,000 shares $197.22 million -6.4%11.5%4.2 $14.84 4/30/202314,200,000 shares $206.18 million -4.6%12.2%4.4 $14.52 4/15/202314,890,000 shares $219.48 million -1.8%12.8%4.7 $14.74 3/31/202315,160,000 shares $251.35 million -13.5%13.4%4.9 $16.58 3/15/202317,520,000 shares $249.66 million +4.6%15.5%6.3 $14.25 2/28/202316,750,000 shares $191.29 million +2.5%15.7%7.3 $11.42 2/15/202316,350,000 shares $199.47 million -12.3%15.3%11.7 $12.20 1/31/202318,650,000 shares $173.07 million +1.3%17.5%14.1 $9.28 1/15/202318,410,000 shares $161.09 million -3.1%17.3%14.7 $8.75 12/30/202219,000,000 shares $144.78 million -1.1%17.9%14.7 $7.62 12/15/202219,210,000 shares $171.16 million -4.5%18.1%14.8 $8.91 11/30/202220,110,000 shares $188.43 million -3.6%18.9%13.3 $9.37 11/15/202220,860,000 shares $217.99 million -6.5%19.7%13 $10.45 10/31/202222,310,000 shares $232.69 million -3.5%21.1%13.4 $10.43 10/15/202223,120,000 shares $228.43 million +0.6%22.0%11.2 $9.88 9/30/202222,980,000 shares $228.42 million -1.2%21.9%11 $9.94 9/15/202223,250,000 shares $277.61 million +0.6%22.2%10.6 $11.94 8/31/202223,110,000 shares $242.66 million +2.9%22.1%10.5 $10.50These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy BBIO Short Interest - Frequently Asked Questions What is BridgeBio Pharma's current short interest? Short interest is the volume of BridgeBio Pharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 15,070,000 shares of BBIO short. 10.86% of BridgeBio Pharma's shares are currently sold short. Learn More on BridgeBio Pharma's current short interest. What is a good short interest ratio for BridgeBio Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BBIO shares currently have a short interest ratio of 9.0. Learn More on BridgeBio Pharma's short interest ratio. Which institutional investors are shorting BridgeBio Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BridgeBio Pharma: Portman Square Capital LLP, Concourse Financial Group Securities Inc., and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for BridgeBio Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.86% of BridgeBio Pharma's floating shares are currently sold short. Is BridgeBio Pharma's short interest increasing or decreasing? BridgeBio Pharma saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 15,070,000 shares, an increase of 5.5% from the previous total of 14,280,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BridgeBio Pharma's float size? BridgeBio Pharma currently has issued a total of 175,830,000 shares. Some of BridgeBio Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BridgeBio Pharma currently has a public float of 138,830,000 shares. How does BridgeBio Pharma's short interest compare to its competitors? 10.86% of BridgeBio Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BridgeBio Pharma: Madrigal Pharmaceuticals, Inc. (17.14%), Nuvalent, Inc. (20.97%), Alpine Immune Sciences, Inc. (7.23%), Organon & Co. (4.29%), Perrigo Company plc (2.88%), Alkermes plc (7.99%), CymaBay Therapeutics, Inc. (5.10%), Ultragenyx Pharmaceutical Inc. (5.32%), Insmed Incorporated (6.33%), Prestige Consumer Healthcare Inc. (3.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short BridgeBio Pharma stock? Short selling BBIO is an investing strategy that aims to generate trading profit from BridgeBio Pharma as its price is falling. BBIO shares are trading up $0.41 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BridgeBio Pharma? A short squeeze for BridgeBio Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BBIO, which in turn drives the price of the stock up even further. How often is BridgeBio Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBIO, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MDGL Short Squeeze NUVL Short Squeeze ALPN Short Squeeze OGN Short Squeeze PRGO Short Squeeze ALKS Short Squeeze CBAY Short Squeeze RARE Short Squeeze INSM Short Squeeze PBH Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BBIO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders